ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,454,580, issued on Oct. 28, was assigned to Regeneron Pharmaceuticals Inc. (Tarrytown, N.Y.).
"FRB antibodies" was invented by Alexander Astrakhan (Seattle).
According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides anti-FRB antibodies or antigen binding fragments thereof that bind an FRB polypeptide."
The patent was filed on April 9, 2021, under Application No. 17/917,418.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=12454580&OS=12454580&RS=12454580
Disclaimer: Curated b...